UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Planning for retirement is crucial for financial security. Find out when to start this important journey and set yourself up for success.
26,825 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
A china tech fund opens a biotech position, signaling a broader shift toward life sciences within tech-driven portfol...
A simple computer moment can signal bigger trouble. This article explains how a watched mouse move laptop moment can ...
Oracle has faced skepticism around AI spending and cloud growth. This article digs into how Oracle's AI-Fueled Growth...
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
A growing scam uses Bitcoin ATMs to pressure victims into sending crypto. San Antonio is posting bilingual warnings d...
A premier eye care company delivers $5.1 billion in revenue, while a prominent investor quietly expands holdings. Her...
As Berkshire Hathaway's leadership evolves, investors wonder if berkshire hathaway greg abel has echoed Warren Buffet...
A couple questions how to allocate a house-down payment fund during a layoff. The Ramsey Show host cautions that dipp...
A sharp move in a gold royalty stock can trigger questions for both traders and long-term investors. This article bre...
Shares in American Eagle Outfitters slid after a disappointing quarterly report. This guide breaks down the key drive...
A new MLP income ETF employs a covered call overlay to lift yield beyond AMLP, drawing attention from income-focused ...